During the Health System Executive Summit, Candy Tsourounis, PharmD, and Elise Wozniak, PharmD got candid about the barriers and financial risk surrounding this innovative therapy.
News|Articles|October 7, 2011
FDA approves tadalafil to treat benign prostatic hyperplasia
FDA has approved tadalafil (Cialis, Eli Lilly) for 3 indications: ED, the signs and symptoms of BPH, and ED and the signs and symptoms of BPH in men who have both conditions.
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Apothecary Pharma recalls compounded tirzepatide and NAD+ vials over sterility concerns
2
Jessica Castle, M.D., discusses CGM’s A1C impact in non-insulin type 2 diabetes
3
Now is the time to get ready for 2027 changes in prior authorization, MA Star Ratings and others in federal healthcare law and regulations
4
On delayed diagnosis and possible causes of hidradenitis suppurativa | A Q&A with Luis Garza, M.D., Ph.D.
5